{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:11:46Z","timestamp":1768036306123,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00467-011-1815-z","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T16:30:51Z","timestamp":1300379451000},"page":"1163-1166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Karyomegalic-like nephropathy, Ewing\u2019s sarcoma and ifosfamide therapy"],"prefix":"10.1007","volume":"26","author":[{"given":"Tom","family":"McCulloch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Prayle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Lunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,1]]},"reference":[{"key":"1815_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/path.1711130303","volume":"113","author":"AF Burry","year":"1974","unstructured":"Burry AF (1974) Extreme dysplasia in renal epithelium of a young woman dying from hepatocarcinoma. J Pathol 113:147\u2013150","journal-title":"J Pathol"},{"key":"1815_CR2","first-page":"54","volume":"12","author":"MJ Mihatsch","year":"1979","unstructured":"Mihatsch MJ, Gudat F, Zollinger HU, Heierli C, Tholen H, Reutter FW (1979) Systemic karyomegaly associated with chronic interstitial nephritis. A new disease entity? Clin Nephrol 12:54\u201362","journal-title":"Clin Nephrol"},{"key":"1815_CR3","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/ndt\/17.11.1914","volume":"17","author":"S Bhandari","year":"2002","unstructured":"Bhandari S, Kalowski S, Collett P, Cooke BE, Kerr P, Newland R, Dowling J, Horvath J (2002) Karyomegalic nephropathy: an uncommon cause of progressive renal failure. Nephrol Dial Transplant 17:1914\u20131920","journal-title":"Nephrol Dial Transplant"},{"key":"1815_CR4","first-page":"1441","volume-title":"Heptinstall\u2019s pathology of the kidney","author":"RB Colvin","year":"2007","unstructured":"Colvin RB, Nikeleit V (2007) Polyomavirus nephropathy. In: Jenette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall\u2019s pathology of the kidney. Lippincott Williams & Wilkins, Philadelphia, pp 1441\u20131447"},{"key":"1815_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0272-6386(95)90005-5","volume":"25","author":"M Spoendlin","year":"1995","unstructured":"Spoendlin M, Moch H, Brunner F, Brunner W, Burger HR, Kiss D, Wegmann W, Dalquen P, Oberholzer M, Thiel G, Mihatsch MJ (1995) Karyomegalic interstitial nephritis: further support for a distinct entity and evidence for a genetic defect. Am J Kidney Dis 25:242\u2013252","journal-title":"Am J Kidney Dis"},{"key":"1815_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5414\/CNP65349","volume":"65","author":"G Monga","year":"2006","unstructured":"Monga G, Banfi G, Salvadore M, Amatruda O, Bozzola C, Mazzucco G (2006) Karyomegalic interstitial nephritis: report of 3 new cases and review of the literature. Clin Nephrol 65:349\u2013355","journal-title":"Clin Nephrol"},{"key":"1815_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1191\/0960327104ht458oa","volume":"23","author":"W Hassen","year":"2004","unstructured":"Hassen W, Abid-Essafi S, Achour A, Guezzah N, Zakhama A, Ellouz F, Creppy EE, Bacha H (2004) Karyomegaly of tubular kidney cells in human chronic interstitial nephropathy in Tunisia: respective role of Ochratoxin A and possible genetic predisposition. Hum Exp Toxicol 23:339\u2013346","journal-title":"Hum Exp Toxicol"},{"key":"1815_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/pbc.20858","volume":"48","author":"W Stohr","year":"2007","unstructured":"Stohr W, Paulides M, Bielack S, Jurgens H, Treuner J, Rossi R, Langer T, Beck JD (2007) Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer 48:447\u2013452","journal-title":"Pediatr Blood Cancer"},{"key":"1815_CR9","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1054\/bjoc.2000.1214","volume":"82","author":"R Skinner","year":"2000","unstructured":"Skinner R, Cotterill SJ, Stevens MC (2000) Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children\u2019s Cancer Study Group. Br J Cancer 82:1636\u20131645","journal-title":"Br J Cancer"},{"key":"1815_CR10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/009127009903900504","volume":"39","author":"R Loebstein","year":"1999","unstructured":"Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, Gobrial M, Baruchel S, Ito S, Koren G (1999) Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 39:454\u2013461","journal-title":"J Clin Pharmacol"},{"key":"1815_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/pbc.22364","volume":"54","author":"R Skinner","year":"2010","unstructured":"Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD (2010) Glomerular toxicity persists 10\u00a0years after ifosfamide treatment in childhood and is not predictable by age or dose. Pediatr Blood Cancer 54:983\u2013989","journal-title":"Pediatr Blood Cancer"},{"key":"1815_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0046-8177(75)80078-5","volume":"6","author":"RE Slavin","year":"1975","unstructured":"Slavin RE, Millan JC, Mullins GM (1975) Pathology of high dose intermittent cyclophosphamide therapy. Hum Pathol 6:693\u2013709","journal-title":"Hum Pathol"},{"key":"1815_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/1097-0142(19950801)76:3<497::AID-CNCR2820760321>3.0.CO;2-C","volume":"76","author":"JS Berns","year":"1995","unstructured":"Berns JS, Haghighat A, Staddon A, Cohen RM, Schmidt R, Fisher S, Rudnick MR, Tomaszewski JE (1995) Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients. Cancer 76:497\u2013500","journal-title":"Cancer"},{"key":"1815_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00292414","volume":"23","author":"PH Willemse","year":"1989","unstructured":"Willemse PH, de Jong PE, Elema JD, Mulder NH (1989) Severe renal failure following high-dose ifosfamide and mesna. Cancer Chemother Pharmacol 23:329\u2013330","journal-title":"Cancer Chemother Pharmacol"},{"key":"1815_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000013321","volume":"18","author":"MM Friedlaender","year":"1998","unstructured":"Friedlaender MM, Haviv YS, Rosenmann E, Peylan-Ramu N (1998) End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy. Am J Nephrol 18:131\u2013133","journal-title":"Am J Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1815-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-011-1815-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1815-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1815-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T20:14:09Z","timestamp":1685996049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-011-1815-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1815"],"URL":"https:\/\/doi.org\/10.1007\/s00467-011-1815-z","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"12 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}